Delhi HC permits Woman To terminate Over 24-Week Pregnancy

The court had appointed a medical board comprising doctors from the All India Institute of Medical Sciences (AIIMS) to examine her and give a report on the advisability of the abortion.

Published On 2021-04-07 03:45 GMT   |   Update On 2021-04-07 08:18 GMT

New Delhi: The Delhi High Court today permitted a woman to abort her more than 24 week pregnancy in view of a medical board's report that the foetus suffers from substantial abnormalities.

Justice Prathiba M Singh noted while passing the order that the medical report also stated that there was a risk to the woman during the pregnancy termination procedure as she was a cardiac patient and was being administered blood thinners.

Advertisement

Also Read: Delhi HC allows terminating 25-week pregnancy

Justice Singh, before granting the permission, also spoke to the woman's husband to find out whether he understood the risks associated with the procedure.

Subsequently, the court allowed the woman to undergo medical termination of pregnancy.

The woman had moved the court in the last week of March seeking to terminate her pregnancy as the foetus was found to be suffering from facial haemorrhage and hydrocephalus during her medical examination.

The court had, thereafter, appointed a medical board comprising doctors from the All India Institute of Medical Sciences (AIIMS) to examine her and give a report on the advisability of the abortion.

The board, in its report, said the procedure posed a risk to the mother as she was a cardiac patient, but recommended termination of the pregnancy as the foetus suffered from substantial abnormalities.

Also Read: Constitute medical board to examine woman seeking termination of pregnancy: Delhi HC to AIIMS

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News